FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.

Patil, A.A., Sayal, P., Depondt, M.L. et al. (9 more authors) (2014) FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents. Oncotarget, 5 (15). pp. 6414-6424. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Copyright : © 2014 Patil et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Glioma; Glioblastoma; Fanconi Anaemia; Temozolomide; Chemo-sensitisation
Dates:
  • Published (online): 16 July 2014
  • Accepted: 14 July 2014
  • Published: August 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 04 Aug 2016 08:45
Last Modified: 04 Aug 2016 08:45
Published Version: http://dx.doi.org/10.18632/oncotarget.2225
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.2225

Share / Export

Statistics